Contact

About

About Us

IVEAcare is developing innovative neuromodulation therapy to treat unmet clinical needs impacting large patient populations.

Leadership

We are serial entrepreneurs, engineers, and investors with extensive experience in implantable medical devices who have successfully developed and commercialized many new therapies in the bioelectronics space. We partner with leading physicians to improve the standard of care in the treatment of chronic conditions.

Todd Kerkow

Co-Founder, President and CEO

Diane Burnside

Vice President, Clinical Affairs

Jake Ludwig

Vice President, Research & Development

Cheryl Swanson

Vice President, Quality and Regulatory Affairs

Founders

Mudit K. Jain

Co-Founder and Chairman of the Board

Lynn Elliott

Co-Founder and Board Member

Investors

desktop_vensana_logo
desktop_NuXcel_logo
desktop_treoventures_logo
desktop_hatteras_logo

Todd Kerkow

Co-Founder, President and CEO

Todd has dedicated his career to develop and commercially deliver medical technology that is meaningful for patients, physicians, and investors.  Todd has worked in large companies (Guidant and Boston Scientific) and small companies (Cameron Health, Microchips Biotech, and Cardionomic). Todd’s passion is working with cross-functional teams to advance innovative medical technology.

Todd is the holder of multiple patents and has a BS and MS in Mechanical Engineering.

Diane Burnside

Vice President, Clinical Affairs

Diane is an accomplished leader with extensive experience in the active implantable and mechanical medical device industry. Diane has worked in small companies such as Mainstay Medical, Kspine and Neurostream and started her career at large corporate companies (Medtronic, Pfizer/AMS, Boston Scientific) which provided the sound foundation for executing successful clinical programs.

Diane’s passion is designing and executing international clinical programs to drive market approval and therapy adoption for innovative medical technologies. Diane holds a patent from her time at Boston Scientific and has a degree in Applied Sciences.

Jake Ludwig

Vice President, Research & Development

Jake brings 20 years of experience in medical device development to the iVEAcare team. He has led both small, dedicated teams and large, cross-functional projects, and has delivered meaningful technology for Cardiac Rhythm Management, Electrophysiology, Endoscopy, and Urology markets.

Jake’s passion is designing and delivering life-saving and life-enhancing medical technology that improves patient outcomes and simplifies therapy delivery for clinicians and caregivers. Jake holds over 20 US patents and has a BS in Electrical and Computer Engineering.

Cheryl Swanson

Vice President, Quality and Regulatory Affairs

Cheryl brings 30 years of extensive experience in the medical device industry, having worked with both large and small companies. Her career includes significant roles at major corporations like Guidant, Boston Scientific, and Medtronic, as well as at smaller firms such as Corventis and V-Wave Medical.

Cheryl’s passions are working with cross-functional teams to develop high quality products and collaborating with regulatory agencies to facilitate global market approvals. Cheryl holds a B.A. in Political Science and an M.S. in Regulatory Affairs.

Mudit K. Jain

Co-Founder and Chairman of the Board

Mudit is a Founding General Partner of Treo Ventures, and the CEO and co-founder of NuXcel, a bioelectronics focused medical device accelerator. Mudit also co-founded ShiraTronics, Inc., where he serves as Chairman of the Board.

Mudit brings over two decades of medical device industry experience across company formation, R&D, business development, and venture capital, with a global perspective on healthcare based on his experiences in USA, Ireland, and India. Mudit has served on the boards of several medical device companies, from early concept to commercial growth stage, resulting in successful IPOs and M&A transactions.

Mudit also serves on the External Advisory Board for Cleveland Clinic Innovations, Board of Visitors of the Graduate School at Duke University, External Advisory Board of John Hopkins University Center for Bioengineering Innovation and Design, and on the Board of One Heart Health, a healthcare focused non-profit focused on providing access to pediatric populations in underprivileged geographies.

Most recently, as a General Partner with Synergy Life Science Partners, Mudit delivered top quartile performance. In addition to his private venture capital experiences at Treo and Synergy Life Science Partners, Mudit also brings a strategic investment perspective gained during his tenure at Johnson & Johnson Development Corporation.

Prior to his investing career, Mudit held operational roles in the Cardiac Rhythm Management Division of Guidant Corporation, developing novel device technologies for heart failure, remote monitoring, and cardiac ablation. Mudit also played an important role in product development for start-ups like Epicor, Inc. (acquired: St. Jude Medical), and Cardiac Pathways Corporation (acquired: Boston Scientific). Mudit holds eight issued patents and has authored several peer reviewed publications.

Mudit has a BE in Electrical Engineering and aPh.D. in Biomedical Engineering.

Lynn Elliott

Co-Founder and Board Member

Lynn brings three decades of active implantable device experience in medical device innovation, R&D, manufacturing, clinical trials, and regulatory approvals to healthcare challenges. Lynn has a unique blend of experience in large medical device companies such as Guidant and Boston Scientific and small venture capital funded startups like Spinal Modulation, SacraMed, and ShiraTronics.

At Guidant, Lynn held leadership positions in Product Development and Research & Advanced Technologies and was a key driver of delivering pacemakers, implantable defibrillators and cardiac resynchronization devices to the global market.

At Spinal Modulation, Lynn held the position of Chief Technology Officer and was a key driver of defining and delivering an innovative neurostimulation device for the management of chronic pain. Spinal Modulation was acquired by St Jude (Abbott).

Lynn holds over 20 US patents and has published numerous articles in peer reviewed publications.  Lynn has a BS in Electrical Engineering and an MS in Software Engineering.